Novartis FDA Panel Approval: ‘Pharma Innovation At Its Best’
Novartis AG’s pioneering cancer drug won the backing of a federal advisory panel Wednesday, paving the way for the first gene therapy to be approved in the United States.
Posted On Jul 13 2017